Germline mutations in 40 cancer susceptibility genes among <scp>C</scp>hinese patients with high hereditary risk breast cancerJunyan Li, Jun Jiang, Yan Xu et al.|International Journal of Cancer|2018Cited by 61
HN1L promotes migration and invasion of breast cancer by up‐regulating the expression of HMGB1Dechuang Jiao, Zhenzhen Liu|Journal of Cellular and Molecular Medicine|2020Cited by 33
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trialXiuchun Chen, Zhenzhen Liu, Dechuang Jiao et al.|The Lancet Oncology|2024Cited by 32
GSDMD contributes to host defence against Staphylococcus aureus skin infection by suppressing the Cxcl1–Cxcr2 axisZhenzhen Liu, Wei Chen|Veterinary Research|2021Cited by 19
Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trialMin Yan, Huajun Li, Limin Niu et al.|Nature Communications|2023Cited by 14